Loading…
Reporting person on SEC Form 4
Christopher R. Fenimore
Christopher R. Fenimore is EVP Finance CFO at Regeneron Pharmaceuticals. OQRO lists 6 transactions filed with the SEC under this name, the latest on Aug 20, 2026, each linked to the official Form 4.
EVP Finance CFO
Disclosures on record
6
Companies involved
1
Disclosure history
Regeneron PharmaceuticalsREGN
6 disclosures · Dec 2025 – Aug 2026
Aug 18, 20266,283disclosed Aug 20
DetailsOfficial recordAug 18, 20266,283disclosed Aug 20
DetailsOfficial record
